Terms: = Cervical cancer AND MDM2, HDM2, 4193, ENSG00000135679, HDMX, MGC71221, hdm2, Q00987
124 results:
1. Integrating network pharmacology approaches for the investigation of multi-target pharmacological mechanism of 6-shogaol against cervical cancer.
Elasbali AM; Al-Soud WA; Mousa Elayyan AE; Al-Oanzi ZH; Alhassan HH; Mohamed BM; Alanazi HH; Ashraf MS; Moiz S; Patel M; Patel M; Adnan M
J Biomol Struct Dyn; 2023; 41(23):14135-14151. PubMed ID: 36943780
[TBL] [Abstract] [Full Text] [Related]
2. Inclusion of Nitrofurantoin into the Realm of cancer Chemotherapy via Biology-Oriented Synthesis and Drug Repurposing.
Elzahhar PA; Nematalla HA; Al-Koussa H; Abrahamian C; El-Yazbi AF; Bodgi L; Bou-Gharios J; Azzi J; Al Choboq J; Labib HF; Kheir WA; Abu-Serie MM; Elrewiny MA; El-Yazbi AF; Belal ASF
J Med Chem; 2023 Apr; 66(7):4565-4587. PubMed ID: 36921275
[TBL] [Abstract] [Full Text] [Related]
3. Lovastatin inhibits the proliferation of human cervical cancer hela cells through the regulation of tp53 pathway by mir-92a-1-5p.
Hu N; Lin J; Gao J; Lin S; Duan S
Pak J Pharm Sci; 2022 Nov; 35(6):1557-1564. PubMed ID: 36789815
[TBL] [Abstract] [Full Text] [Related]
4. The role of PICT1 in RPL11/mdm2/p53 pathway-regulated inhibition of cell growth induced by topoisomerase IIα inhibitor against cervical cancer cell line.
Rao Z; Shen J; Wang J; Zhang Z; Zhou J; Zhu J; Chen J; Chen W; Wang H
Biochem Pharmacol; 2022 Jul; 201():115098. PubMed ID: 35605655
[TBL] [Abstract] [Full Text] [Related]
5. Farnesoid X receptor functions in cervical cancer via the p14
Huang X; Wang B; Shen H; Huang D; Shi G
Mol Biol Rep; 2022 May; 49(5):3617-3625. PubMed ID: 35347542
[TBL] [Abstract] [Full Text] [Related]
6. LOC100130075 Promotes cervical cancer Progression by Activating mdm2 Transcription through E2F1.
Xu Y; Liu Y; Huang W; Yang C; Wang Y
Reprod Sci; 2022 May; 29(5):1439-1448. PubMed ID: 35201567
[TBL] [Abstract] [Full Text] [Related]
7. A small-molecule inhibitor of MDMX suppresses cervical cancer cells via the inhibition of E6-E6AP-p53 axis.
Zhang J; Yu G; Yang Y; Wang Y; Guo M; Yin Q; Yan C; Tian J; Fu F; Wang H
Pharmacol Res; 2022 Mar; 177():106128. PubMed ID: 35150860
[TBL] [Abstract] [Full Text] [Related]
8. An unusual approach for a cervical mass: sternotomy for the treatment of a giant cervico-thoracic lipoma.
Petruzzi G; Trozzi L; Moretto S; De Virgilio A; Melis E; Gallina FT; Pichi B; Campo F; Facciolo F; Pellini R
Acta Biomed; 2022 Jan; 92(6):e2021477. PubMed ID: 35075061
[TBL] [Abstract] [Full Text] [Related]
9. Stereoselective Synthesis of the Di-Spirooxindole Analogs Based Oxindole and Cyclohexanone Moieties as Potential Anticancer Agents.
Al-Majid AM; Ali M; Islam MS; Alshahrani S; Alamary AS; Yousuf S; Choudhary MI; Barakat A
Molecules; 2021 Oct; 26(20):. PubMed ID: 34684885
[TBL] [Abstract] [Full Text] [Related]
10. PICT1 is critical for regulating the Rps27a-mdm2-p53 pathway by microtubule polymerization inhibitor against cervical cancer.
Wang H; Zhao J; Yang J; Wan S; Fu Y; Wang X; Zhou T; Zhang Z; Shen J
Biochim Biophys Acta Mol Cell Res; 2021 Sep; 1868(10):119084. PubMed ID: 34166715
[TBL] [Abstract] [Full Text] [Related]
11. RPL34-AS1-induced RPL34 inhibits cervical cancer cell tumorigenesis via the mdm2-P53 pathway.
Zhu Y; Ren C; Jiang D; Yang L; Chen Y; Li F; Wang B; Zhang Y
Cancer Sci; 2021 May; 112(5):1811-1821. PubMed ID: 33675124
[TBL] [Abstract] [Full Text] [Related]
12. Lipopolysaccharide Affects the Proliferation and Glucose Metabolism of cervical cancer Cells Through the FRA1/mdm2/p53 Pathway.
Jiang X; Yuan J; Dou Y; Zeng D; Xiao S
Int J Med Sci; 2021; 18(4):1030-1038. PubMed ID: 33456361
[TBL] [Abstract] [Full Text] [Related]
13. Long non-coding RNA TUG1 sponges microRNA-381-3p to facilitate cell viability and attenuate apoptosis in cervical cancer by elevating mdm2 expression.
Liu J; Wu D; Lin X; Hong Y; Wang X; Zheng C; Wu Z; Hong Y; Lv Y
Life Sci; 2021 Feb; 267():118902. PubMed ID: 33340525
[TBL] [Abstract] [Full Text] [Related]
14. Therapeutic potential of p53 reactivation in cervical cancer.
Zhao X; Sun W; Ren Y; Lu Z
Crit Rev Oncol Hematol; 2021 Jan; 157():103182. PubMed ID: 33276182
[TBL] [Abstract] [Full Text] [Related]
15. IU1 suppresses proliferation of cervical cancer cells through mdm2 degradation.
Xu L; Wang J; Yuan X; Yang S; Xu X; Li K; He Y; Wei L; Zhang J; Tian Y
Int J Biol Sci; 2020; 16(15):2951-2963. PubMed ID: 33061808
[TBL] [Abstract] [Full Text] [Related]
16. Clinicopathological and Molecular Differences Between Gastric-type Mucinous Carcinoma and Usual-type Endocervical Adenocarcinoma of the Uterine Cervix.
Jung H; Bae GE; Kim HM; Kim HS
Cancer Genomics Proteomics; 2020; 17(5):627-641. PubMed ID: 32859641
[TBL] [Abstract] [Full Text] [Related]
17. F-box protein FBXO31 modulates apoptosis and epithelial-mesenchymal transition of cervical cancer via inactivation of the PI3K/AKT-mediated mdm2/p53 axis.
Liu K; Xue B; Bai G; Zhang W
Life Sci; 2020 Oct; 259():118277. PubMed ID: 32800832
[TBL] [Abstract] [Full Text] [Related]
18. Role of the RNA-binding protein La in cancer pathobiology.
Sommer G; Heise T
RNA Biol; 2021 Feb; 18(2):218-236. PubMed ID: 32687431
[TBL] [Abstract] [Full Text] [Related]
19. Synthesis, Antitumor Evaluation, Molecular Modeling and Quantitative Structure-Activity Relationship (QSAR) of Novel 2-[(4-Amino-6-
Tomorowicz Ł; Sławiński J; Żołnowska B; Szafrański K; Kawiak A
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32331219
[TBL] [Abstract] [Full Text] [Related]
20. All-trans retinoic acid enhances the effect of Fra-1 to inhibit cell proliferation and metabolism in cervical cancer.
Dou Y; Huang D; Zeng X; Zhou Y; Jiang X; Yue C; He J; Xiao S
Biotechnol Lett; 2020 Jun; 42(6):1051-1060. PubMed ID: 32124141
[TBL] [Abstract] [Full Text] [Related]
[Next]
